Editorial Commentary
Bridging histopathology, inferred transcriptomics, and immunotherapy response prediction in head and neck cancer
Translational Cancer Research
2026;
15
(2)
:71
.
(28 February 2026)
Integrating tumor regression and nodal status for refined prognostication after neoadjuvant therapy in esophageal cancer: where does TRG-N fit in the evolving global landscape?
Translational Cancer Research
2026;
15
(2)
:72
.
(28 February 2026)
Improving stratification in HPV-negative head and neck squamous cell carcinoma (HNSCC) using emerging immune-based biomarkers
Translational Cancer Research
2026;
15
(2)
:73
.
(28 February 2026)
Timing matters: concurrent vs. sequential immunotherapy in combination with chemoradiation in head and neck cancer
Translational Cancer Research
2026;
15
(2)
:74
.
(28 February 2026)
Early clearance of circulating tumor DNA as a determinant of induction therapy response in human papillomavirus-associated oropharyngeal squamous cell carcinoma
Translational Cancer Research
2026;
15
(2)
:75
.
(28 February 2026)
Original Article
Single-cell analysis of UNC13D-mediated immune and dedifferentiation heterogeneity in acute myeloid leukemia and development of a prognostic model
Translational Cancer Research
2026;
15
(2)
:76
.
(28 February 2026)
Multi-omics analysis of BTF3L4 as a prognostic and immune biomarker in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(2)
:77
.
(28 February 2026)
A novel prognostic model based on vasculogenic mimicry in ovarian cancer
Translational Cancer Research
2026;
15
(2)
:78
.
(28 February 2026)
Ability of lactylation-related genes to stratify patients with ovarian cancer and predict immunotherapy response
Translational Cancer Research
2026;
15
(2)
:79
.
(28 February 2026)
Cuprotosis-related gene subtypes, prognostic modeling, and tumor microenvironment remodeling in breast cancer
Translational Cancer Research
2026;
15
(2)
:80
.
(28 February 2026)
Enhanced CT-based deep learning radiomics and biological correlations for predicting immunotherapy efficacy in advanced non-small cell lung cancer
Translational Cancer Research
2026;
15
(2)
:81
.
(28 February 2026)
Bioinformatics analysis of the expression and prognostic significance of depression-related genes in lung adenocarcinoma
Translational Cancer Research
2026;
15
(2)
:82
.
(28 February 2026)
HOXB8 promotes invasion and metastasis of high-grade serous ovarian cancer via suppression of the KDM6B/C/EBPα signaling axis
Translational Cancer Research
2026;
15
(2)
:83
.
(28 February 2026)
Metastatic patterns, prognostic factors, and deep learning model development in primary gastrointestinal melanoma: a retrospective cohort analysis
Translational Cancer Research
2026;
15
(2)
:84
.
(28 February 2026)
Development and internal validation of a prognostic model for hepatocellular carcinoma after liver resection based on the albumin-bilirubin score and triglyceride-glucose index
Translational Cancer Research
2026;
15
(2)
:85
.
(28 February 2026)
Prediction of overall survival in patients with hepatocellular carcinoma and second primary malignancies: a prognostic model based on the SEER database
Translational Cancer Research
2026;
15
(2)
:86
.
(28 February 2026)
Prognostic significance of lymph node-related indices and a novel nomogram for rectal cancer patients with synchronous liver metastases after the preoperative chemoradiotherapy: a population-based study
Translational Cancer Research
2026;
15
(2)
:87
.
(28 February 2026)
Bioinformatics identification of adenosylhomocysteinase (AHCY) as a regulator of ferroptosis in nasopharyngeal carcinoma cells via the Hippo-Yes-associated protein (Hippo-YAP) pathway
Translational Cancer Research
2026;
15
(2)
:88
.
(28 February 2026)
Pan-cancer analysis identifies FAM111B as a biomarker for immune suppression microenvironment in low-grade gliomas
Translational Cancer Research
2026;
15
(2)
:89
.
(28 February 2026)
Identification of immune-related targets of N6-methyladenosine regulators in hepatocellular carcinoma via RNA-seq analysis
Translational Cancer Research
2026;
15
(2)
:90
.
(28 February 2026)
A multimodal fusion model for bone tumor benign and malignant diagnosis: development and validation with clinical text and radiographs
Translational Cancer Research
2026;
15
(2)
:91
.
(28 February 2026)
Expression analyses of fatty acid binding proteins (FABPs) in breast cancer subtypes: implications for immune modulation and clinical outcomes
Translational Cancer Research
2026;
15
(2)
:92
.
(28 February 2026)
Mechanistic study of the role of emodin in targeting and inhibiting the Rap1 signaling pathway to regulate epithelial-mesenchymal transition and reverse cisplatin resistance in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(2)
:93
.
(28 February 2026)
Comprehensive analysis of liquid-liquid phase separation-related genes in osteosarcoma: implications for prognosis, immune infiltration and drug sensitivity
Translational Cancer Research
2026;
15
(2)
:94
.
(28 February 2026)
Single-cell RNA sequencing identifies cancer-associated fibroblast marker genes for determining cancer subtypes in oral squamous cell carcinoma and predicting patient prognosis
Translational Cancer Research
2026;
15
(2)
:95
.
(28 February 2026)
Interpretable machine learning-based survival prediction and key gene identification in cancer using gene expression and clinical data
Translational Cancer Research
2026;
15
(2)
:96
.
(28 February 2026)
Combinatorial treatment with donafenib and quercetin suppresses lipid metabolism in HepG2 cells by targeting the CREB1/DRP1/SREBP1 axis
Translational Cancer Research
2026;
15
(2)
:97
.
(28 February 2026)
Construction and validation of a palmitoylation-related prognostic model for lung adenocarcinoma based on integrated bioinformatics and machine learning
Translational Cancer Research
2026;
15
(2)
:98
.
(28 February 2026)
Tumor habitat characteristics derived from intravoxel incoherent motion for early response assessment in soft tissue sarcoma undergoing neoadjuvant radiotherapy and targeted therapy: a phase II study
Translational Cancer Research
2026;
15
(2)
:99
.
(28 February 2026)
Prognostic prediction and immune correlation analysis of anoikis- and epithelial-mesenchymal transition-related genes in lung adenocarcinoma
Translational Cancer Research
2026;
15
(2)
:100
.
(28 February 2026)
Efficacy and safety of programmed cell death protein 1/programmed death-ligand 1 inhibitors combined with chemotherapy for breast cancer: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(2)
:101
.
(28 February 2026)
Comprehensive analysis identifies PKMYT1 as an oncogene and potential prognostic and immunological biomarker in lung adenocarcinoma
Translational Cancer Research
2026;
15
(2)
:102
.
(28 February 2026)
Brain tumor detection based on transcription regulation features identified from public cerebrospinal fluid cell-free DNA sequencing data
Translational Cancer Research
2026;
15
(2)
:103
.
(28 February 2026)
Multiomics study on the tertiary lymphatic structure signature of colon cancer
Translational Cancer Research
2026;
15
(2)
:104
.
(28 February 2026)
Development and validation of a ferroptosis-related gene signature for prognostic prediction and therapeutic target identification in invasive lobular carcinoma
Translational Cancer Research
2026;
15
(2)
:105
.
(28 February 2026)
Investigating the material basis and molecular mechanisms of Oldenlandia diffusa in the treatment of papillary thyroid carcinoma: a network pharmacology and experimental study
Translational Cancer Research
2026;
15
(2)
:106
.
(28 February 2026)
Identification and validation of a novel estrogen-related model for breast cancer to predict the prognosis
Translational Cancer Research
2026;
15
(2)
:107
.
(28 February 2026)
COL10A1 transcriptional regulation of ANXA5-mediated ferroptosis is involved in malignant progression of head and neck squamous cell carcinoma
Translational Cancer Research
2026;
15
(2)
:108
.
(28 February 2026)
Tumor-intrinsic B4GALNT3 expression drives a protective immune microenvironment in endometriosis-associated ovarian cancer
Translational Cancer Research
2026;
15
(2)
:109
.
(28 February 2026)
Exploring the lactate-metabolism related characteristics during the development of medulloblastoma through single-cell and bulk RNA-seq
Translational Cancer Research
2026;
15
(2)
:110
.
(28 February 2026)
Multi-parameter magnetic resonance imaging (MRI) deep learning radiomics predicts complete response after induction immunochemotherapy in locally advanced nasopharyngeal carcinoma
Translational Cancer Research
2026;
15
(2)
:111
.
(28 February 2026)
BACE2 facilitates lung adenocarcinoma progression by enhancing mTORC1 signalling
Translational Cancer Research
2026;
15
(2)
:112
.
(28 February 2026)
A novel gene signature based on Like-Smith family members-related genes for predicting the prognosis of hepatocellular carcinoma
Translational Cancer Research
2026;
15
(2)
:113
.
(28 February 2026)
Efficacy and potential mechanism of main active ingredients of Astragalus membranaceus in animals with hepatocellular carcinoma: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(2)
:114
.
(28 February 2026)
Prognostic impact of cancer-directed surgery in primary pulmonary lymphoma: a population-based, propensity score-matched analysis
Translational Cancer Research
2026;
15
(2)
:115
.
(28 February 2026)
Transmembrane protein 9 as a novel biomarker promotes oral squamous cell carcinoma growth via IL1RN and serves as an immune therapeutic target
Translational Cancer Research
2026;
15
(2)
:116
.
(28 February 2026)
Development and validation of an 11-CpG methylation signature-based nomogram for predicting prognosis in early-onset breast cancer
Translational Cancer Research
2026;
15
(2)
:117
.
(28 February 2026)
CNN3 promotes angiogenesis in osteosarcoma, associated with upregulating VEGF-A and enhancing endothelial cell activity
Translational Cancer Research
2026;
15
(2)
:118
.
(28 February 2026)
Efficacy of transarterial chemoembolization combined with PD-1 versus PD-L1 inhibitors in mass-forming intrahepatic cholangiocarcinoma: a multicenter retrospective study
Translational Cancer Research
2026;
15
(2)
:119
.
(28 February 2026)
Causal relationship between metabolic syndrome and gastric cancer: insights from comprehensive analysis and biomarker identification
Translational Cancer Research
2026;
15
(2)
:120
.
(28 February 2026)
Rosa roxburghii Tratt fruit polysaccharides inhibit proliferation and induce apoptosis in human cervical cancer cell line
Translational Cancer Research
2026;
15
(2)
:121
.
(28 February 2026)
Pathological features and biomarkers of hepatocellular carcinoma: a bibliometric analysis from 2005 to 2025
Translational Cancer Research
2026;
15
(2)
:122
.
(28 February 2026)
A panel of machine learning approaches for diagnostic model development and validation in ovarian cancer
Translational Cancer Research
2026;
15
(2)
:123
.
(28 February 2026)
Construction of a postoperative disease-free survival prediction model for non-small cell lung cancer patients based on dual-energy computed tomography parameters and blood inflammatory indicators
Translational Cancer Research
2026;
15
(2)
:124
.
(28 February 2026)
ITPG: an immune-related transcriptomic predictive model for gastric cancer prognosis
Translational Cancer Research
2026;
15
(2)
:125
.
(28 February 2026)
A risk score model based on glycosylation-related genes for predicting radioresistance and prognosis of lung adenocarcinoma
Translational Cancer Research
2026;
15
(2)
:126
.
(28 February 2026)
The value of an integrated multi-omics model in the diagnosis of benign and malignant pulmonary nodules
Translational Cancer Research
2026;
15
(2)
:127
.
(28 February 2026)
Mature tertiary lymphoid structures tumor microenvironment-based risk model to assess patients with pancreatic ductal adenocarcinoma
Translational Cancer Research
2026;
15
(2)
:128
.
(28 February 2026)
Construction and validation of a prognostic model associated with chromatin remodeling in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(2)
:129
.
(28 February 2026)
Greater susceptibility of patients with idiopathic pulmonary fibrosis to basal cell carcinoma: a combined genomics and Mendelian randomization analysis
Translational Cancer Research
2026;
15
(2)
:130
.
(28 February 2026)
Neoadjuvant androgen deprivation therapy with bicalutamide compared to hormonal agents in treating high-risk prostate cancer: a real-world cohort study
Translational Cancer Research
2026;
15
(2)
:131
.
(28 February 2026)
Salvia miltiorrhiza-derived microRNA58 inhibits tumor growth by targeting Krüppel-like factor 3 in human endothelial cells
Translational Cancer Research
2026;
15
(2)
:132
.
(28 February 2026)
Review Article
Current status and advances in research on the impact and mechanisms of atmospheric pollutants on gastric cancer: a narrative review
Translational Cancer Research
2026;
15
(2)
:133
.
(28 February 2026)
Case Report
A case report of idiopathic pulmonary fibrosis concurrent with EGFR 19 deletion lung adenocarcinoma
Translational Cancer Research
2026;
15
(2)
:134
.
(28 February 2026)
B-cell lymphoma initially presenting as isolated pleural effusion: a challenging diagnostic case report
Translational Cancer Research
2026;
15
(2)
:135
.
(28 February 2026)
Letter to the Editor
Does coordinated targeting of metabolism and autophagy, modulated by microtubule dynamics, influence therapeutic vulnerability to eribulin in glioblastoma?
Translational Cancer Research
2026;
15
(2)
:136
.
(28 February 2026)
